Analytical validation of whole exome and whole genome sequencing for clinical applications
about
Achieving high-sensitivity for clinical applications using augmented exome sequencingMedical implications of technical accuracy in genome sequencingHuman Knockout Carriers: Dead, Diseased, Healthy, or Improved?Impact of New Genomic Technologies on Understanding Adverse Drug ReactionsMedical genomics: The intricate path from genetic variant identification to clinical interpretationDeep sequencing of 10,000 human genomesGenomic profiling reveals mutational landscape in parathyroid carcinomasReducing INDEL calling errors in whole genome and exome sequencing data.Comparison among three variant callers and assessment of the accuracy of imputation from SNP array data to whole-genome sequence level in chicken.SAAS-CNV: A Joint Segmentation Approach on Aggregated and Allele Specific Signals for the Identification of Somatic Copy Number Alterations with Next-Generation Sequencing Data.Replicate exome-sequencing in a multiple-generation family: improved interpretation of next-generation sequencing data.Identification of a novel RASD1 somatic mutation in a USP8-mutated corticotroph adenoma.Detailed comparison of two popular variant calling packages for exome and targeted exon studiesEffectiveness of exome and genome sequencing guided by acuity of illness for diagnosis of neurodevelopmental disorders.Personalized sequencing and the future of medicine: discovery, diagnosis and defeat of disease.ClinLabGeneticist: a tool for clinical management of genetic variants from whole exome sequencing in clinical genetic laboratories.New COL6A6 variant detected by whole-exome sequencing is linked to break points in intron 4 and 3'-UTR, deleting exon 5 of RHO, and causing adRP.A somatic reference standard for cancer genome sequencing.Responsible implementation of expanded carrier screening.Integrating precision cancer medicine into healthcare-policy, practice, and research challenges.The Allelic Landscape of Human Blood Cell Trait Variation and Links to Common Complex Disease.Validation and Utilization of a Clinical Next-Generation Sequencing Panel for Selected Cardiovascular Disorders.Reference standards for next-generation sequencing.Effect of lossy compression of quality scores on variant calling.Cross-Comparison of Exome Analysis, Next-Generation Sequencing of Amplicons, and the iPLEX(®) ADME PGx Panel for Pharmacogenomic ProfilingGenetic identification of a common collagen disease in puerto ricans via identity-by-descent mapping in a health system.Novel, compound heterozygous, single-nucleotide variants in MARS2 associated with developmental delay, poor growth, and sensorineural hearing loss.Exome sequencing of extreme clopidogrel response phenotypes identifies B4GALT2 as a determinant of on-treatment platelet reactivity.Insights into beta cell regeneration for diabetes via integration of molecular landscapes in human insulinomas.Experience of a multidisciplinary task force with exome sequencing for Mendelian disorders.Blood collection in cell-stabilizing tubes does not impact germline DNA quality for pediatric patients.Novel pedigree analysis implicates DNA repair and chromatin remodeling in multiple myeloma risk.Novel findings with reassessment of exome data: implications for validation testing and interpretation of genomic data.Polygenic Risk of Spasmodic Dysphonia is Associated With Vulnerable Sensorimotor Connectivity.Germline mutations in lysine specific demethylase 1 (LSD1/KDM1A) confer susceptibility to multiple myeloma.Identification of STAC3 variants in non-Native American families with overlapping features of Carey-Fineman-Ziter syndrome and Moebius syndrome.Measuring coverage and accuracy of whole-exome sequencing in clinical contextClinical cancer genomic profiling by three-platform sequencing of whole genome, whole exome and transcriptome
P2860
Q22000581-BBC2537E-BAFF-40D1-A539-F070B7045707Q23005220-A4D98589-B9A8-4F6D-AFCD-ADAEA3AC87FBQ26764736-C4A54F2A-D6DE-4D65-829D-8D370F03B1AFQ26787099-ECB13163-E386-4984-AC2C-3EDE17A55747Q26824974-41617873-3FA1-495C-9B67-E32171B38BEEQ27133767-8D3F3FB4-951E-40B8-AE32-17B69491112CQ30360213-10C7FE23-D74B-49D6-BC8D-7614D2655A90Q30872081-584C3FF7-FEDF-4209-8923-00EC9F59D7BBQ31008999-3EC6002C-90F9-4B02-B7BF-306BCD477B36Q31026307-23D3B3E5-DFD7-461D-97F4-946CDBFA23C0Q31027821-B54ED4B3-5298-4FEA-AF77-34D325A7CA99Q33622368-FC67B380-14B0-4FF3-B841-73A50E1FFA28Q34285275-92B6D2EC-B55C-4090-8258-C2792CCAD3F1Q34866575-4B2D0079-5AF8-4151-89D6-E24209EBFE2AQ35107992-28B6CA3F-DB5C-40CF-82CF-60389897157BQ35764300-0E88FFEB-4083-4B92-91C2-4E219ABE8E8CQ35962525-AEE979B8-FD32-4167-B4FB-CE014E7AFEE3Q35994200-2C6DF130-D056-4376-A2B0-DCD8A9C637DCQ36902740-E9AB7E5D-A5FE-43BE-BD73-67258F3B9839Q37360550-75571266-1B1B-4DB4-85A9-B183CC33DB62Q37634534-ECDE3ACC-25AA-4D43-8762-7127F4880925Q37699545-ADCFE944-5CEC-4DD4-8ADA-E9D9D665D581Q38669617-B5F3914A-7414-4B13-979F-ED33CA6B2056Q38896729-4D094C0E-1559-415C-889D-1D63548C323DQ38910521-6D690C92-24C5-4D0F-84FE-43FF753E1A65Q40045934-405CCDAA-F3A0-4E86-A712-A63EB1A90728Q40901341-700E9362-874C-4318-B324-BB4B7D2DC96DQ42245258-2705FB18-023B-488C-8B8C-27BCF2E2E65BQ42282703-524B13ED-5BAB-4154-8CE8-77D285F2FDCDQ42531229-F7900413-8604-495C-AA1B-482097A6D796Q47170265-B4E18971-1C5C-42B4-8F22-8A960DC97E26Q48124027-5AF7F8F2-7C79-4012-A4F2-0E8A5CA17852Q48516627-E1187173-BD11-4390-87E4-FFCE5C19B08AQ50105827-D83EBA21-C3F5-4993-92B7-95EC022B8923Q52646188-CD9F4D8A-C09C-4980-A759-E30590BCA9B9Q54132256-EC92314B-2AD7-4273-8522-4365F9EF49E5Q57646393-6680D4AA-A53D-4805-B9AE-1142B8AB1C78Q59129106-5AFA7C18-CF9D-4632-B734-7443EB377223
P2860
Analytical validation of whole exome and whole genome sequencing for clinical applications
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Analytical validation of whole ...... cing for clinical applications
@ast
Analytical validation of whole ...... cing for clinical applications
@en
type
label
Analytical validation of whole ...... cing for clinical applications
@ast
Analytical validation of whole ...... cing for clinical applications
@en
prefLabel
Analytical validation of whole ...... cing for clinical applications
@ast
Analytical validation of whole ...... cing for clinical applications
@en
P2093
P2860
P356
P1433
P1476
Analytical validation of whole ...... cing for clinical applications
@en
P2093
Eric E Schadt
Hardik Shah
Lisa Edelmann
Michael D Linderman
Milind Mahajan
Omar Jabado
Ruth Kornreich
Tracy Brandt
Yumi Kasai
P2860
P2888
P356
10.1186/1755-8794-7-20
P577
2014-04-23T00:00:00Z
P5875
P6179
1017823326